![Bill Rote](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 31/08/2026
William E.
Rote is Chief Research Officer at Travere Therapeutics, Inc. since 2017.
Former positions include Executive Director-Biologics Development at Corvas International, Inc. from 1993 to 2003, Non Executive Director at Xenome Ltd. in 2009, Vice President, Head-Research & Development at Amylin Pharmaceuticals, Inc. from 2012 to 2014, Principal at Eli Lilly & Co., Chief Operating Officer at Psylin Neurosciences, Inc., and Vice President-Clinical Development at Ardea Biosciences, Inc. from 2014 to 2016.
Education includes undergraduate and doctorate degrees from The Pennsylvania State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/09/2026 | 98.197 ( 0,11 % ) | 7 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/02/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Corporate Officer/Principal | 01/07/2016 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Director Técnico/Científico/I+D | 01/07/2014 |
Corvas International, Inc.
 Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Corporate Officer/Principal | 01/01/2003 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Psylin Neurosciences, Inc.
 Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide hormones for the treatment of psychiatric disorders | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide hormones for the treatment of psychiatric disorders | Health Technology |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide pharmaceuticals | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
